188 related articles for article (PubMed ID: 35077850)
1. Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors.
Zhang TJ; Zhang Y; Zhang ZH; Wang ZR; Zhang X; Hu SS; Lu PF; Guo S; Meng FH
Bioorg Med Chem Lett; 2022 Mar; 60():128582. PubMed ID: 35077850
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole Derivatives as Xanthine Oxidase Inhibitors.
Li SY; Zhang TJ; Wu QX; Olounfeh KM; Zhang Y; Meng FH
Med Chem; 2020; 16(1):119-127. PubMed ID: 30963981
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.
Zhang TJ; Wu QX; Li SY; Wang L; Sun Q; Zhang Y; Meng FH; Gao H
Bioorg Med Chem Lett; 2017 Aug; 27(16):3812-3816. PubMed ID: 28693909
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.
Sun M; Zhao J; Mao Q; Yan C; Zhang B; Yang Y; Dai X; Gao J; Lin F; Duan Y; Zhang T; Wang S
Bioorg Med Chem; 2021 May; 38():116117. PubMed ID: 33838610
[TBL] [Abstract][Full Text] [Related]
9. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
Liu X; Chen R; Shang Y; Jiao B; Huang C
Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, inhibition properties against xanthine oxidase and molecular docking studies of dimethyl N-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate and (N-benzyl-1H-1,2,3-triazole-4,5-diyl)dimethanol derivatives.
Yagiz G; Noma SAA; Altundas A; Al-Khafaji K; Taskin-Tok T; Ates B
Bioorg Chem; 2021 Mar; 108():104654. PubMed ID: 33493930
[TBL] [Abstract][Full Text] [Related]
11. Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives.
Zhang B; Dai X; Bao Z; Mao Q; Duan Y; Yang Y; Wang S
Eur J Med Chem; 2019 Nov; 181():111559. PubMed ID: 31376568
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
13. Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.
Yang C; Liu Y; Tu Y; Li L; Du J; Yu D; He P; Wang T; Liu Y; Chen H; Li Y
Bioorg Chem; 2023 Feb; 131():106320. PubMed ID: 36527991
[TBL] [Abstract][Full Text] [Related]
14. N-(3-cyano-1H-indol-5-yl)isonicotinamide and N-(3-cyano-1H-indol-5-yl)-1H-benzo[d]imidazole-5-carboxamide derivatives: Novel amide-based xanthine oxidase inhibitors.
Tu S; Zhang TJ; Zhang Y; Zhang X; Zhang ZH; Meng FH
Bioorg Chem; 2021 Oct; 115():105181. PubMed ID: 34329991
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
16. Amide-based xanthine oxidase inhibitors bearing an N-(1-alkyl-3-cyano-1H-indol-5-yl) moiety: Design, synthesis and structure-activity relationship investigation.
Zhang TJ; Tu S; Zhang X; Wang QY; Hu SS; Zhang Y; Zhang ZH; Wang ZR; Meng FH
Bioorg Chem; 2021 Dec; 117():105417. PubMed ID: 34673452
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors.
Mao Q; Dai X; Xu G; Su Y; Zhang B; Liu D; Wang S
Eur J Med Chem; 2019 Nov; 181():111558. PubMed ID: 31369933
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.
Huang D; Li W; Zhao Y; Xie C; Luo X; Wu F; Xu Z; Sun Q; Liu G
Eur J Med Chem; 2024 May; 271():116443. PubMed ID: 38691887
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Jang JW; Kim TH; Park H; Park WS; Jung SH; Kim GT
Bioorg Med Chem Lett; 2016 Feb; 26(3):950-954. PubMed ID: 26774578
[TBL] [Abstract][Full Text] [Related]
20. Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl)methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors.
Zhang TJ; Li SY; Yuan WY; Wu QX; Wang L; Yang S; Sun Q; Meng FH
Bioorg Med Chem Lett; 2017 Feb; 27(4):729-732. PubMed ID: 28131711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
